Total Live Articles: 430

Cerebral Venous Sinus Thrombosis (CVST)

National Clinical Guideline for Stroke 2023.

Cerebral Venous Sinus Thrombosis (CVST)

Cerebral venous sinus thrombosis (CVST) is a rare form of stroke caused by a blood clot within the dural venous sinuses.

Relevant Anatomy

The brain is drained by a venous system

  • Cerebral veins drain blood from the brain tissue itself
  • Cerebral veins drain into the dural venous sinuses – large venous channels located between layers of the dura mater
  • Dural venous sinuses also receive CSF via arachnoid granulations, and carry blood to the internal jugular vein

Key dural venous sinuses:

Dural venous sinus Location / anatomical relevance
Superior sagittal sinus Runs along the top midline of the skull

Most commonly affected in CVST

Inferior sagittal sinus Runs along the lower free edge of the falx cerebri
Straight sinus Located at the junction of the falx cerebri and tentorium cerebelli

Receives venous drainage from the inferior sagittal sinus, then drains into the confluence of sinuses

Transverse sinuses Run laterally from the back of the skull
Sigmoid sinuses Continue from the transverse sinuses and drain into the internal jugular veins
Cavernous sinus Either side of the sella turcica

Contains CN III, IV, V1, V2, VI and ICA

Causes and Risk Factors

[Ref]

Category Risk factors
Oestrogen-related factors The following contribute to marked female predominance (3x risk than men) in CVST cases among young adults (women of childbearing age account for 70-80% of cases)

  • Pregnancy and postpartum period (nearly 60% of pregnancy-related strokes are attributed to CVST)
  • COCP and oestrogen-containing HRT
  • Obesity
Infections
  • COVID-19
  • Local infections adjacent to the venous sinuses, esp.
    • Otitis media
    • Mastoiditis
    • Sinusitis
Thrombophilia
  • Genetic causes (e.g. Factor V Leiden mutation, antithrombin deficiency)
  • Acquired causes
    • APS
    • Malignancy
    • Nephrotic syndrome (due to renal antithrombin loss)
    • Myeloproliferative disorders and JAK2 mutations
Direct injury and other triggers Physical or mechanical disruptions can also provoke thrombosis

  • Head trauma / injuries
  • Neurosurgical interventions, lumbar puncture
  • Compressive lesions
  • Dehydration

Clinical Features

Onset of CVST: [Ref]

  • Subacute (over 48 hours and 4 weeks) in ~60% cases
  • Acute (under 48 hours) in ~37% cases

Typical clinical features: [Ref]

  • Headache most common symptom (typically diffuse / generalised, worsening gradually over days and is not relieved by sleep)
  • Focal neurological deficit (esp. motor weakness)
    • Unlike in typical arterial strokes, neurological deficits in CVST do NOT localise to a single vascular territory
    • Cerebral dysfunction (e.g. aphasia, neglect) may occur but are less typical than in arterial stroke
  • Seizures (esp. focal seizure, which may progress into generalised seizure or status epilepticus)
  • Signs of raised ICP (e.g. papilloedema, diplopia, nausea and vomiting)

Severe presentations may occur with straight sinus involvement, extensive thrombosis, or severe venous infarction with haemorrhagic transformation, leading to encephalopathy, reduced consciousness or coma.

Cavernous sinus thrombosis – a specific form of venous sinus thrombosis involving the cavernous sinus, typically presents as:

  • Fever (often infective in origin, e.g. sinusitis)
  • Periorbital swelling / oedema
  • Proptosis, chemosis, ophthalmoplegia, diplopia
  • Reduced visual acuity
  • Reduced corneal reflex / facial sensory loss (from CN V1 and V2 involvement)

Secondary intracranial haemorrhage is an important complication of CVST, usually due to venous congestion and haemorrhagic venous infarction. [Ref]

It may present as intraparenchymal haemorrhage, subarachnoid haemorrhage or other patterns of intracranial bleeding. [Ref]

Investigation and Diagnosis

In short, investigation of choice: CT / MR venogram

  • CT venogram is often performed initially, esp. in the acute setting
  • MR venogram is the gold standard with superior sensitivity
  • Diagnostic finding: filling defect or absent flow within a dural venous sinus or cortical vein

In practice, there are 2 main clinical scenarios:

Scenario Approach
CVST is strongly suspected based on clinical features and history Investigation of choice: CT / MR venogram to confirm the diagnosis

A non-contrast CT head is usually performed together with the venogram to look for haemorrhage, mass effect and alternative diagnoses.

Acute stroke is suspected generally Initial investigation: non-contrast CT head

If CT shows features suggestive of CVST (e.g. hyperdense clot within a dural venous sinus or cortical vein) → urgent CT / MR venogram to confirm the diagnosis

Management

Primary initial treatment: full-dose anticoagulation with heparin

  • It is very common for a CVST to cause a secondary cerebral haemorrhage
  • Full-dose anticoagulation must still be given even if imaging shows a secondary cerebral haemorrhage

Long-term maintenance therapy:

  • Warfarin for at least 3 months (target INR: 2-3)

The following are NOT recommended:

  • DOACs (even though they are widely used as 1st line anticoagulation in VTEs)
  • Corticosteroids
  • Reperfusion therapy (thrombolysis and thrombectomy)

References

Related Articles

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.